Researchers at the University of Kentucky (UK) are part of a groundbreaking clinical trial exploring the use of medical ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

"As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal," the Princess of Wales ...

The president-elect said he had an "obligation" to attack one specific late night host. A photo shared by Vice President ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

CNBC's Angelica Peebles talks to Structure Therapeutics CEO Ray Stevens about the obesity landscape and why there's still ...

Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades,” said ...

(“Alpha”) of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets ) (“ZUNVEY ... characterized by progressive decline in memory and other cognitive functions, among which some of the ...

Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.

Statins: For statins, the side effects can be surprising. Some people taking these medications have been found to gain weight ...